Literature DB >> 14666364

Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.

A Gastaldelli1, E Ferrannini, Y Miyazaki, M Matsuda, R A DeFronzo.   

Abstract

AIMS/HYPOTHESIS: Both insulin resistance and beta-cell dysfunction play a role in the transition from normal glucose tolerance (NGT) to Type 2 diabetes (T2DM) through impaired glucose tolerance (IGT). The aim of the study was to define the level of glycaemia at which beta-cell dysfunction becomes evident in the context of existing insulin resistance.
METHODS: Insulin response (OGTT) and insulin sensitivity (euglycaemic insulin clamp) were evaluated in 388 subjects in the San Antonio Metabolism (SAM) study (138 NGT, 49 IGT and 201 T2DM). In all subjects the insulin secretion/insulin resistance index (DeltaI/DeltaG/IR) was calculated as the ratio of the increment in plasma insulin to the increment in plasma glucose during the OGTT divided by insulin resistance, as measured during the clamp.
RESULTS: In lean NGTs with a 2-h plasma glucose concentration (2-h PG) between 5.6 and 6.6 and between 6.7 and 7.7 mmol/l, there was a progressive decline in DeltaI/DeltaG/IR compared with NGTs with a 2-h PG less than 5.6 mmol/l. There was a further decline in DeltaI/DeltaG/IR in IGTs with a 2-h PG between 7.8 and 9.3 and between 9.4 and 11.0 mmol/l, and in Type 2 diabetic patients with a 2-h PG greater than 11.1 mmol/l. Lean and obese subjects showed coincident patterns of relation of 2-h PG to DeltaI/DeltaG/IR. CONCLUSION/
INTERPRETATION: When the plasma insulin response to oral glucose is related to the glycaemic stimulus and severity of insulin resistance, there is a progressive decline in beta-cell function that begins in "normal" glucose tolerant individuals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666364     DOI: 10.1007/s00125-003-1263-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  51 in total

Review 1.  Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.

Authors:  S E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

Review 3.  Glucose toxicity.

Authors:  L Rossetti; A Giaccari; R A DeFronzo
Journal:  Diabetes Care       Date:  1990-06       Impact factor: 19.112

4.  Low insulin response: a marker of prediabetes.

Authors:  S Efendic; V Grill; R Luft; A Wajngot
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

Review 5.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance.

Authors:  K S Polonsky; J Sturis; G I Bell
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

Review 6.  Glucagon-like peptides.

Authors:  D J Drucker
Journal:  Diabetes       Date:  1998-02       Impact factor: 9.461

7.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.

Authors:  B C Martin; J H Warram; A S Krolewski; R N Bergman; J S Soeldner; C R Kahn
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

8.  Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

Authors:  L Rossetti; G I Shulman; W Zawalich; R A DeFronzo
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

9.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

Authors:  S Lillioja; D M Mott; B V Howard; P H Bennett; H Yki-Järvinen; D Freymond; B L Nyomba; F Zurlo; B Swinburn; C Bogardus
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

10.  Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic sujbjects.

Authors:  M J Perley; D M Kipnis
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  111 in total

1.  Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study.

Authors:  Leonard C Glass; Kenneth Cusi; Rachele Berria; Roberta Petz; Eugenio Cersosimo; Ralph A Defronzo; Amalia Gastaldelli
Journal:  Clin Endocrinol (Oxf)       Date:  2010-04-23       Impact factor: 3.478

2.  re: Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA (2004) Beta cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31-39.

Authors:  A B Jenkins; S M Furler; L V Campbell
Journal:  Diabetologia       Date:  2004-08-18       Impact factor: 10.122

3.  Insulin secretion and impaired glucose tolerance.

Authors:  A B Jenkins; L V Campbell
Journal:  Diabetologia       Date:  2010-05-22       Impact factor: 10.122

4.  To: Godsland IF, Jeffs JA, Johnston DG (2004) loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157-1166.

Authors:  M A Abdul-Ghani; R A DeFronzo
Journal:  Diabetologia       Date:  2005-08-17       Impact factor: 10.122

5.  Enhanced activation of phospholipase C and insulin secretion from islets incubated in fatty acid-free bovine serum albumin.

Authors:  Walter S Zawalich; Kathleen C Zawalich
Journal:  Metabolism       Date:  2008-02       Impact factor: 8.694

6.  Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose.

Authors:  Muhammad Abdul-Ghani; Hussein Al Jobori; Giuseppe Daniele; John Adams; Eugenio Cersosimo; Curtis Triplitt; Ralph A DeFronzo
Journal:  Diabetes       Date:  2017-06-13       Impact factor: 9.461

7.  Glucose-stimulated oxidative stress in mononuclear cells is related to pancreatic β-cell dysfunction in polycystic ovary syndrome.

Authors:  Steven K Malin; John P Kirwan; Chang Ling Sia; Frank González
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

8.  Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity?

Authors:  G Bedogni; G Grugni; G Tringali; N Marazzi; A Sartorio
Journal:  J Endocrinol Invest       Date:  2015-04-04       Impact factor: 4.256

9.  The relative associations of β-cell function and insulin sensitivity with glycemic status and incident glycemic progression in migrant Asian Indians in the United States: the MASALA study.

Authors:  Unjali P Gujral; K M Venkat Narayan; Steven E Kahn; Alka M Kanaya
Journal:  J Diabetes Complications       Date:  2013-10-11       Impact factor: 2.852

10.  Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study.

Authors:  R A DeFronzo; M A Banerji; G A Bray; T A Buchanan; S Clement; R R Henry; A E Kitabchi; S Mudaliar; N Musi; R Ratner; P Reaven; D C Schwenke; F D Stentz; D Tripathy
Journal:  Diabetologia       Date:  2009-12-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.